| Title |
The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)
|
|---|---|
| Published in |
Oncolytic Virotherapy, January 2015
|
| DOI | 10.2147/ov.s59640 |
| Pubmed ID | |
| Authors |
Caroline J Breitbach, John C Bell, Tae-Ho Hwang, David H Kirn, James Burke |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 66 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 11 | 17% |
| Researcher | 8 | 12% |
| Student > Master | 7 | 11% |
| Other | 3 | 5% |
| Student > Postgraduate | 3 | 5% |
| Other | 10 | 15% |
| Unknown | 24 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 15 | 23% |
| Agricultural and Biological Sciences | 9 | 14% |
| Medicine and Dentistry | 6 | 9% |
| Immunology and Microbiology | 4 | 6% |
| Chemistry | 2 | 3% |
| Other | 3 | 5% |
| Unknown | 27 | 41% |